These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 19787605)
1. Optical coherence tomography in neovascular age related macular degeneration compared to fluorescein angiography and visual acuity. Henschel A; Spital G; Lommatzsch A; Pauleikhoff D Eur J Ophthalmol; 2009; 19(5):831-5. PubMed ID: 19787605 [TBL] [Abstract][Full Text] [Related]
2. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Eter N; Spaide RF Retina; 2005 Sep; 25(6):691-6. PubMed ID: 16141855 [TBL] [Abstract][Full Text] [Related]
3. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization. Khurana RN; Dupas B; Bressler NM Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027 [TBL] [Abstract][Full Text] [Related]
4. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. Salinas-Alamán A; García-Layana A; Maldonado MJ; Sainz-Gómez C; Alvárez-Vidal A Am J Ophthalmol; 2005 Jul; 140(1):23-8. PubMed ID: 15922284 [TBL] [Abstract][Full Text] [Related]
5. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ; Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095 [TBL] [Abstract][Full Text] [Related]
6. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Costa RA; Farah ME; Cardillo JA; Calucci D; Williams GA Retina; 2003 Apr; 23(2):159-65. PubMed ID: 12707593 [TBL] [Abstract][Full Text] [Related]
11. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography. Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386 [TBL] [Abstract][Full Text] [Related]
12. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. Kashani AH; Keane PA; Dustin L; Walsh AC; Sadda SR Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3366-73. PubMed ID: 19168893 [TBL] [Abstract][Full Text] [Related]
13. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Sayanagi K; Sharma S; Yamamoto T; Kaiser PK Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732 [TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020 [TBL] [Abstract][Full Text] [Related]
15. Early optical coherence tomography changes after photodynamic therapy in patients with age-related macular degeneration. Ozdemir H; Karacorlu SA; Karacorlu M Am J Ophthalmol; 2006 Mar; 141(3):574-6. PubMed ID: 16490515 [TBL] [Abstract][Full Text] [Related]
16. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years. Spielberg L; Leys A Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659 [TBL] [Abstract][Full Text] [Related]
17. Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Montero JA; Ruiz-Moreno JM; Tavolato M Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):797-802. PubMed ID: 14605900 [TBL] [Abstract][Full Text] [Related]
18. Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration. Lie S; Aue A; Sacu S; Simader C; Polak K; Schmidt-Erfurth U Acta Ophthalmol; 2010 Mar; 88(2):212-7. PubMed ID: 19016662 [TBL] [Abstract][Full Text] [Related]
19. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography. Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]